The Latest Breaking News on Pharma

Amid prevalent COVID-19 cases, vaccine pioneer Pfizer (PFE) is significantly benefiting. Moreover, the company beat wall street expectations in the third quarter with a robust financial result and raised its revenue and EPS guidance for the year. Given its strong fundamentals, the stock could be a wise addition to your…

The app Visible is also geared towards people living with conditions such as chronic fatigue syndrome

After signs of cooling inflation, investors are hopeful that the Fed will slow its rate hikes over the coming months. With surging optimism, fundamentally strong stocks Merck (MRK), Coca-Cola (KO), and Verizon (VZ), which have seen increased insider buying, might be ideal investments now. Continue reading.

Fentanyl has become a scourge across America and is taking a toll on the growing number of people living on the streets of Los Angeles

New data reveals that since 2015 there has been a 170 per cent rise in sleeping pill prescriptions to youngsters aged 18 and under

The FDA said Monday it will perform a speedy review of Sarepta Therapeutics' muscular dystrophy gene therapy, and SRPT stock jumped.

Axsome Therapeutics said its Alzheimer's treatment met the goals of a study, sending its shares into the stratosphere, while Biogen's Alzheimer's effort had a setback.

Both monkeypox and mpox will be used by WHO over the next year as the term "monkeypox" is phased out,

Science.org reported Sunday that a woman participating in the joint Biogen-Eisai Clarity AD trial of an experimental Alzheimer's treatment has died of a brain hemorrhage.